CHIMERIC THERAPEUTICS (CHM), who else is jumping on this big train of revenue.??, page-34

For what it's worth I haven't looked too closely at CHM yet as no prospect of taking part in the IPO. $35m would be a good chance to get through phase II, but phase III trials are expensive and by that point CHM will be years in of trial costs + working capital. A raise would be a certainty if trying to go it alone through Phase III, but knowing Hopper's preference with other companies they would be aiming for a partnership or T/O by that stage.

Good luck to everyone, IMU is my favourite stock on the ASX and excited to see what some familiar faces can manage here. Will certainly be taking an interest if the price dips at some stage.